Arteris: Accelerating Growth, Expanding AI-Driven Demand, and a Clear Path to Profitability Support Buy Rating

Analyst Joshua Buchalter of TD Cowen maintained a Buy rating on Arteris, with a price target of $21.00.

Joshua Buchalter has given his Buy rating due to a combination of factors tied to Arteris’ accelerating growth and improving profitability profile. He highlights that annualized contract value plus royalties and remaining performance obligations both reached record levels, with revenue and AI-related contributions surpassing management guidance, signaling robust demand and strong execution.

He also points to expanding customer adoption, including new FlexNoC design wins, a deeper relationship with NXP, and added hardware security content from the Cycuity acquisition, which broadens the addressable market. In addition, the company’s 2026 outlook projects revenue and ACV plus royalties growing above 20% with a path to non-GAAP break-even, making the leverage in its license-and-royalty model particularly attractive in a volatile semiconductor environment.

Based on the recent corporate insider activity of 144 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AIP in relation to earlier this year.